Location: Home
  • search
  • go
  • Relate News
  • 7/2/2021At A Glance: Pharmaceutical Merger Review in China
  • 6/30/2021HUTCHMED Launches $325M Initial Public Offering in Hong Kong
  • 6/30/2021Recent Executive Moves
  • 6/30/2021IQVIA: Potential of Chinese Pharma Lies in the Country's Huge Patient ...
  • 6/30/2021IQVIA: Chinese Retail Pharmacy Sales Down 1.4% in Q1/2021
  • 6/30/2021Listed Domestic Pharma Cos See Sharp Performance Growth in Q1
  • 6/30/2021Financial-related Company News in Brief
  • 6/29/2021Innovent Granted Chinese Approval of TYVYT in Combo with BYVASDA as...
  • 6/29/2021Vivoryon and Simcere Announce Licensing Deal for N3pE Amyloid-targetin...
  • 6/28/2021WuXi STA Plans Pharmaceutical Chemical Facility in Delaware
  • 6/28/2021PharmaDJ's China Biotech Fundraising Tracker: April 2021
  • 6/25/2021AZ's Pulmicort, Bayer's Xarelto Among Big Losers in China's Largest Ro...
  • 6/24/2021NMPA Issues the Provisions for Registration of Licensed Pharmacists
  • 6/24/2021China Concludes the 5th Round of National Level VBP, Slashing Average ...
  • 6/24/2021NMPA Revises Packages Insert of Oxiracetam Formulations and Injectable...
  • 6/23/2021Online Platform Operator Medlive Tech Advances Plans for Hong Kong IPO
  • 6/23/2021HUTCHMED's Orpathys Conditionally Approved in China for NSCLC
  • 6/23/2021Innovent's Sintilimab in Combo with Chemotherapy Meets Primary Endpoin...
  • 6/22/2021Innovent's Pemazyre (pemigatinib) Approved in Taiwan
  • 6/22/2021Hutchmed Granted Chinese Approval of Surufatinib (Sulanda) for Advance...
  • 6/22/2021China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hep...
  • 6/21/2021AZ/MSD Granted New Indication for Lynparza (olaparib) in China
  • 6/21/2021China and U.K. Initiate Drug Regulatory Cooperation Project
  • 6/18/2021NHSA Announces Outcome of Its Inventory Survey for Drugs Included in t...
  • 6/18/2021Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance...
  • 6/18/2021Recent Executive Moves
  • 6/18/2021PharmaDJ's China Licensing Deals Tracker: April 2021
  • 6/17/2021Can-Fite Receives Notice of Patent Allowance in China for NASH Treatme...
  • 6/17/2021MacroGenics and Zai Lab Enter into Broad Strategic Deal for Preclinica...
  • 6/17/2021Sirnaomics Announces NMPA IND Acceptance for Global Multicenter Phase ...
  • Page:91/360 Total number of articles:10791: [First][<<] [89] [90] [91] [92] [93] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group